CORESTEM Inc (166480) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.103x

Based on the latest financial reports, CORESTEM Inc (166480) has a cash flow conversion efficiency ratio of -0.103x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.18 Billion ≈ $-2.83 Million USD) by net assets (₩40.62 Billion ≈ $27.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CORESTEM Inc net asset quality index to measure how much of total assets are equity-financed.

CORESTEM Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how CORESTEM Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CORESTEM Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

CORESTEM Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CORESTEM Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
OTRS AG F:TR9	0.155x
Shanghai Guijiu Co Ltd SHG:600696	0.031x
Mnc Sky Vision Tbk JK:MSKY	0.133x
PTRB KLSE:0260	-0.140x
Openbase Inc KQ:049480	0.018x
SBF AG F:CY1K	N/A
Iktinos Hellas S.A. Greek Marble Industry Technical and Touristic Company AT:IKTIN	-0.030x
Candles Scandinavia AB Series B ST:CANDLE-B	-0.085x

Annual Cash Flow Conversion Efficiency for CORESTEM Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of CORESTEM Inc from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see CORESTEM Inc stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩48.59 Billion ≈ $32.93 Million	₩-21.12 Billion ≈ $-14.31 Million	-0.435x	+45.73%
2023-12-31	₩19.60 Billion ≈ $13.28 Million	₩-15.70 Billion ≈ $-10.64 Million	-0.801x	-294.34%
2022-12-31	₩41.46 Billion ≈ $28.10 Million	₩-8.42 Billion ≈ $-5.71 Million	-0.203x	+1.23%
2021-12-31	₩37.19 Billion ≈ $25.20 Million	₩-7.65 Billion ≈ $-5.18 Million	-0.206x	-290.05%
2020-12-31	₩41.29 Billion ≈ $27.98 Million	₩4.47 Billion ≈ $3.03 Million	0.108x	+1260.00%
2019-12-31	₩57.70 Billion ≈ $39.10 Million	₩-538.08 Million ≈ $-364.65K	-0.009x	+48.55%
2018-12-31	₩62.24 Billion ≈ $42.18 Million	₩-1.13 Billion ≈ $-764.48K	-0.018x	+81.10%
2017-12-31	₩65.60 Billion ≈ $44.46 Million	₩-6.29 Billion ≈ $-4.26 Million	-0.096x	-282.69%
2016-12-31	₩66.73 Billion ≈ $45.22 Million	₩3.50 Billion ≈ $2.37 Million	0.053x	+424.60%
2015-12-31	₩63.04 Billion ≈ $42.72 Million	₩-1.02 Billion ≈ $-691.01K	-0.016x	+87.47%
2014-12-31	₩18.97 Billion ≈ $12.86 Million	₩-2.45 Billion ≈ $-1.66 Million	-0.129x	--

About CORESTEM Inc

KQ:166480 Korea Biotechnology

Market Cap

$36.21 Million

₩53.44 Billion KRW

Market Cap Rank

#23052 Global

#1496 in Korea

Share Price

₩1902.00

Change (1 day)

+5.14%

52-Week Range

₩1060.00 - ₩4800.00

All Time High

₩32150.00